RxMP Therapeutics LLC
Processing red blood-cell particles to treat excessive bleeding
This article was originally published in Start Up
RxMP Therapeutics LLC is working to resolve excessive diffuse bleeding that is often associated with trauma, and also with certain orthopedic and cardiovascular surgeries. The start-up believes it can successfully treat excessive diffuse bleeding with particles produced from the membranes of red blood cells that have been freeze-dried and then, literally, blown to bits.
You may also be interested in...
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.
Top executives from the pharmaceutical industry and direct-to-consumer marketing are teaming up with leading dermatologists and manufacturers of skin-care products to create RegimenMD, a new hybrid business model that is part bricks-and-mortar, part Internet-based and completely in tune with the times.